What is the catalog number for Parvin alpha/PARVA Rabbit Polyclonal Antibody?

The catalog number for Parvin alpha/PARVA Rabbit Polyclonal Antibody is orb308850.

What sizes are available for Parvin alpha/PARVA Rabbit Polyclonal Antibody?

Parvin alpha/PARVA Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is Parvin alpha/PARVA Rabbit Polyclonal Antibody in stock?

Parvin alpha/PARVA Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Parvin alpha/PARVA Rabbit Polyclonal Antibody

Product Specifications

Product Name Alternative

Alpha-parvin; Actopaxin; CH-ILKBP; Calponin-like integrin-linked kinase-binding protein; Matrix-remodeling-associated protein 2; PARVA; MXRA2

UniProt

Q9NVD7

Reactivity

Human, Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence in the middle region of human Parvin alpha, identical to the related mouse sequence, and different from the related rat sequence by one amino acid.

Target

Alpha-parvin

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Immunology & Inflammation, Neuroscience, Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Human Western blot, 0.1-0.5μg/ml, Human, Mouse, Rat

Form

Lyophilized

Molecular Weight

42 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.